Literature DB >> 24595898

Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases: is there a causal link?

Giovanni Targher1, Christopher D Byrne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24595898     DOI： 10.1007/s12020-014-0220-3

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  9 in total

Review 1.  Vitamin D, thrombosis, and hemostasis: more than skin deep.

Authors:  Giovanni Targher; Isabella Pichiri; Giuseppe Lippi
Journal:  Semin Thromb Hemost       Date:  2012-02-07       Impact factor: 4.180

Review 2.  Update in vitamin D.

Authors:  John S Adams; Martin Hewison
Journal:  J Clin Endocrinol Metab       Date:  2010-02       Impact factor: 5.958

3.  High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome.

Authors:  Eun-Jung Rhee; Mee Kyoung Kim; Se Eun Park; Cheol-Young Park; Ki Hyun Baek; Won-Young Lee; Moo Il Kang; Sung-Woo Park; Sun-Woo Kim; Ki Won Oh
Journal:  Endocr J       Date:  2013-02-13       Impact factor: 2.349

4.  Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease.

Authors:  K L Jablonski; A Jovanovich; J Holmen; G Targher; K McFann; J Kendrick; M Chonchol
Journal:  Nutr Metab Cardiovasc Dis       Date:  2013-02-13       Impact factor: 4.222

Review 5.  Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels.

Authors:  Giovanni Targher; Eleonora Scorletti; Alessandro Mantovani; Christopher D Byrne
Journal:  Metab Syndr Relat Disord       Date:  2013-06-07       Impact factor: 1.894

6.  Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.

Authors:  Giovanni Targher; Lorenzo Bertolini; Luca Scala; Massimo Cigolini; Luciano Zenari; Giancarlo Falezza; Guido Arcaro
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-08-22       Impact factor: 4.222

7.  Vitamin D status, liver enzymes, and incident liver disease and mortality: a general population study.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Anders Borglykke; Torben Jørgensen; Betina Heinsbæk Thuesen; Charlotta Pisinger; Lars Ebbe Schmidt; Allan Linneberg
Journal:  Endocrine       Date:  2013-11-23       Impact factor: 3.633

8.  Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes.

Authors:  Ilaria Barchetta; Francesco Angelico; Maria Del Ben; Marco Giorgio Baroni; Paolo Pozzilli; Sergio Morini; Maria Gisella Cavallo
Journal:  BMC Med       Date:  2011-07-12       Impact factor: 8.775

9.  Association between serum 25(OH) vitamin D, incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.

Authors:  J-B Wang; C C Abnet; W Chen; S M Dawsey; J-H Fan; L-Y Yin; J Yin; J M Major; P R Taylor; Y-L Qiao; N D Freedman
Journal:  Br J Cancer       Date:  2013-09-05       Impact factor: 7.640
  9 in total
  3 in total

1.  Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial.

Authors:  Nasrin Sharifi; Reza Amani; Eskandar Hajiani; Bahman Cheraghian
Journal:  Endocrine       Date:  2014-06-27       Impact factor: 3.633

Review 2.  Nutritional issues in patients with obesity and cirrhosis.

Authors:  Luigi Schiavo; Luca Busetto; Manuela Cesaretti; Shira Zelber-Sagi; Liat Deutsch; Antonio Iannelli
Journal:  World J Gastroenterol       Date:  2018-08-14       Impact factor: 5.742

3.  Effect of Vitamin D Deficiency on Liver Cancer Risk: A Systematic Review and Meta-Analysis.

Authors:  Zhenghui Yi; Linjie Wang; Xiangqun Tu
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.